Peter Arend

Dr. Peter Arend


Research Focus & Metrics

Academic Career Length

58Years (1969-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2021 in Immunobiology
Verified
Journal Article
Open access
PAPeter Arend
Peter Arend
While the angiotensin converting enzyme 2 (ACE2) protein is defined as the primary severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptor, the viral serine molecule might be mobilized by the host's transmembrane protease serine subtype 2 (TMPRSS2) enzyme from the viral spike (S) protein and hijack the host’s N-acetyl-D-galactosamine (GalNAc) metabolism. The resulting hybrid, serologically A-like/Tn (T nouvelle) structure potentially acts as a host–pathogen functional molecular bridge. In humans, this intermediate structure will hypothetically be replaced by ABO(H) blood group-specific, mucin-type structures, in the case of infection hybrid epitopes, implicating the phenotypically glycosidic accommodation of plasma proteins. The virus may, by mimicking the synthetic pathways of the ABO(H) blood groups, bind to the cell surfaces of the blood group O(H) by formation of a hybrid H-type antigen as the potential precursor of hybrid non-O blood groups, which does not affect the highly anti-glycan aggressive anti-A and anti-B isoagglutinin activities, exerted by the germline-encoded nonimmune immunoglobulin M (IgM). In the non-O blood groups, which have developed from the H-type antigen, these IgM activities are downregulated by phenotypic glycosylation, while adaptive immunoglobulins might arise in response to the hybrid A and B blood group structures, bonds between autologous carbohydrates and foreign peptides, suggesting the exertion of autoreactivity. The non-O blood groups thus become a preferred target for the virus, whereas blood group O(H) individuals, lacking the A/B phenotype-determining enzymes and binding the virus alone by hybrid H-type antigen formation, have the least molecular contact with the virus and maintain the critical anti-A and anti-B isoagglutinin activities, exerted by the ancestral IgM, which is considered the humoral spearhead of innate immunity.

1 September 1977 in Nature
Verified
Journal Article
Closed access
PAPeter Arend
Peter Arend
JNJ. Nijssen
J. Nijssen

12 May 2018 in Annals of the New York Academy of Sciences
Verified
Journal Article
Open access
PDF file
PAPeter Arend
Peter Arend
The human ABO(H) blood group phenotypes arise from the evolutionarily oldest genetic system found in primate populations. While the blood group antigen A is considered the ancestral primordial structure, under the selective pressure of life‐threatening diseases blood group O(H) came to dominate as the most frequently occurring blood group worldwide. Non‐O(H) phenotypes demonstrate impaired formation of adaptive and innate immunoglobulin specificities due to clonal selection and phenotype formation in plasma proteins. Compared with individuals with blood group O(H), blood group A individuals not only have a significantly higher risk of developing certain types of cancer but also exhibit high susceptibility to malaria tropica or infection by Plasmodium falciparum. The phenotype‐determining blood group A glycotransferase(s), which affect the levels of anti‐A/Tn cross‐reactive immunoglobulins in phenotypic glycosidic accommodation, might also mediate adhesion and entry of the parasite to host cells via trans‐species O‐GalNAc glycosylation of abundantly expressed serine residues that arise throughout the parasite's life cycle, while excluding the possibility of antibody formation against the resulting hybrid Tn antigen. In contrast, human blood group O(H), lacking this enzyme, is indicated to confer a survival advantage regarding the overall risk of developing cancer, and individuals with this blood group rarely develop life‐threatening infections involving evolutionarily selective malaria strains.

1 December 1976 in International Journal of Immunogenetics
Verified
Journal Article
Closed access
PDF file
PAPeter Arend
Peter Arend
JNJ. Nijssen
J. Nijssen

1 May 2013 in Immunobiology
Verified
Journal Article
Open access
PAPeter Arend
Peter Arend
According to N.K. Jerne the somatic generation of immune recognition occurs in conjunction with germ cell evolution and precedes the formation of the zygote, i.e. operates before clonal selection. We propose that it is based on interspecies inherent, ancestral forces maintaining the lineage. Murine oogenesis may be offered as a model. So in C57BL/10BL sera an anti-A reactive, mercapto-ethanol sensitive glycoprotein of up to now unknown cellular origin, but exhibiting immunoglobulin M character, presents itself "complementary" to a syngeneic epitope, which encoded by histocompatibility gene A or meanwhile accepted ancestor of the ABO gene family, arises predominantly in ovarian tissue and was detected statistically significant exclusively in polar glycolipids. Reports either on loss, pronounced expressions or de novo appearances of A-type structures in various conditions of accelerated growth like germ cell evolution, wound healing, inflammation and tumor proliferation in man and ABO related animals might show the dynamics of ancestral functions guarantying stem cell fidelity in maturation and tissue renewal processes. Procedures vice versa generating pluripotent stem cells for therapeutical reasons may indicate, that any artificially started growth should somehow pass through the germ line from the beginning, where according to growing knowledge exclusively the oocyte's genome provides a completely channeling ancestral information. In predatory animals such as the modern-day sea anemone, ancestral proteins, particularly those of the p53 gene family govern the reproduction processes, and are active up to the current mammalian female germ line. Lectins, providing the dual function of growth promotion and defense in higher plants, are suggested to represent the evolutionary precursors of the mammalian immunoglobulin M molecules, or protein moiety implying the greatest functional diversity in nature. And apart from any established mammalian genetic tree, a common vetch like Vicia cracca, may represent an ancient model of protected reproduction mirroring A-reactive "complementarity" already in a plant. The in its seeds developed, and from the number of chromosomes depending amount of an anti-A(1) specific glycoprotein suggests promotion of germination while simultaneously exerting protection from a soil bacterium, which intriguingly is immobilized by human anti-A immunoglobulin as well. Moreover, in a mammalian ovary the lectin of Dolichos biflorus detects again histo (blood) group A-determining N-acetyl-d-galactosamine epitopes, here signalizing activity of embryonic stem cells. So apparently based on identical, ancestral structures, the dual function of growth promotion and defense, predetermined in a plant genome, might be preserved right up to dominate early mammalian ontogeny.

1 December 2011 in Immunobiology
Verified
Journal Article
Open access
PAPeter Arend
Peter Arend
The "inappropriate" A-specific ovarian glycosphingolipids discovered in unfertilized C57BL/10J female mice reflect growth processes, which suggest the activity of embryonic stem cells undergoing genetic polymorphism. And the responding anti-GalNAc antibody represents the first classical "natural" antibody, which was unmasked as a highly specific autoantibody. This murine anti-A is subspecifically distinct from the human antibody, discovering by a broader reactivity growth-dependent, xenoreactive A-specific structures also in non-reproductive murine tissues, where an equivalent of the human AB gene family as a cis AB-gene encodes A-and B glycotransferases. Expression of antigen is known to need always more than its encoded enzyme, and the special mechanism which in the C57BL/10J murine ovarian glycospingolipids blocks the expression of "B" still remains still unknown. A herewith arising postulation of a growth-predominating common biological activity may be supported by findings in rats. The number of A-genes here significantly exceeds those of B and in the Wistar rat the A-antigen is only expressed in the wild type, while B-expression requires the transfer of human B. Nevertheless in transgenic rats, the appearance of "A" still remains more pronounced. The observations lead to reports on animals, which do not show AB transferase production or a respective antigen expression in their normal tissues, but inconcistently display A activity in malignant tumors. And respective examples are delivered by phenotype independent neo expressions of "inappropriate" A-specific structures in human cancer. Although in comparison with epitope deletions they are rare, the ubiquitous "natural" (IgM and IgG) anti-A and anti-B levels, against self and not self, irrespective of the blood group in any normal human sera, may reflect invisible "inappropriate" A-specific growth. The role of the associated (auto) anti-B might be different, because B-neo expressions obviously not occur in cancer, and anti-gal-antibodies are supposed to originate primarily from environmental, cross-reactive stimulation, and beyond their functions in defense are otherwise engaged in physiology. In general natural antibody specificities undergo significant phylogenetical changes within the species. However, the in nature wide-spread "natural" anti-A agglutinin specificities survived or even predominated the long-term evolution from the brown trout up to man and still respond to the biological power, i.e. the products of a CAZY glycosyltransferase 6 (ABO) gene family. It is so hypothesized that both, the murine and human "natural" anti-A antibodies represent examples of a still to be analyzed polyclonal response to a provocative, species-independent evolutionary epitope, which arises or escapes by some enzymatic predominance from the genetical polymorphism in a consistent developmental process.